As of 2024-12-14, the Fair Value of Abionyx Pharma SA (ABNX.PA) is -0.48 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.31 EUR, the upside of Abionyx Pharma SA is -137.02%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 1.85 | -1.89 | -5.82 | -4.21 | -3.52 | -2.72 |
| YoY growth | 129.32% | -202.00% | -208.70% | 27.76% | 16.36% | -47.45% |
| Market Cap (mil) | 45.36 |
| P/E | |
| Forward P/E |
| EPS | -0.10 |
| Avg earnings growth rate | -47.45% |
| TTM earnings | -3.36 |